Tobacco Exposure and Influencing Factors of Smoking Cessation Among Chronic Kidney Disease Patients - Trial NCT06303089
Access comprehensive clinical trial information for NCT06303089 through Pure Global AI's free database. This phase not specified trial is sponsored by Sun Yat-sen University and is currently Not yet recruiting. The study focuses on Smoking Cessation. Target enrollment is 554 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Sun Yat-sen University
Timeline & Enrollment
N/A
Apr 01, 2024
Mar 01, 2025
Primary Outcome
Prevalence of current smokers,Abstinence rates
Summary
The purpose of this study is to describe the tobacco exposure and characteristics of patients
 with Chronic Kidney Disease (CKD) who quit smoking, to identify patients' tobacco-related
 knowledge, attitude, and practice (KAP) and explore the influencing factors of smoking
 cessation.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06303089
Non-Device Trial